Royce & Associates’s Chembio diagnostics, Inc. CEMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-135,800
| Closed | -$49K | – | 999 |
|
|
2022
Q3 | $49K | Hold |
135,800
| – | – | ﹤0.01% | 923 |
|
|
2022
Q2 | $88K | Hold |
135,800
| – | – | ﹤0.01% | 923 |
|
|
2022
Q1 | $111K | Sell |
135,800
-178,553
| -57% | -$146K | ﹤0.01% | 947 |
|
|
2021
Q4 | $358K | Sell |
314,353
-177,100
| -36% | -$202K | ﹤0.01% | 916 |
|
|
2021
Q3 | $1.23M | Hold |
491,453
| – | – | 0.01% | 797 |
|
|
2021
Q2 | $1.46M | Hold |
491,453
| – | – | 0.01% | 804 |
|
|
2021
Q1 | $1.73M | Hold |
491,453
| – | – | 0.01% | 779 |
|
|
2020
Q4 | $2.33M | Hold |
491,453
| – | – | 0.02% | 697 |
|
|
2020
Q3 | $2.39M | Sell |
491,453
-92,889
| -16% | -$451K | 0.03% | 647 |
|
|
2020
Q2 | $1.9M | Sell |
584,342
-590,974
| -50% | -$1.92M | 0.02% | 675 |
|
|
2020
Q1 | $6.02M | Buy |
1,175,316
+183,824
| +19% | +$941K | 0.08% | 320 |
|
|
2019
Q4 | $4.52M | Buy |
991,492
+375,874
| +61% | +$1.71M | 0.04% | 512 |
|
|
2019
Q3 | $3.77M | Buy |
615,618
+146,465
| +31% | +$896K | 0.03% | 546 |
|
|
2019
Q2 | $2.86M | Hold |
469,153
| – | – | 0.03% | 631 |
|
|
2019
Q1 | $2.6M | Hold |
469,153
| – | – | 0.02% | 664 |
|
|
2018
Q4 | $2.66M | Buy |
469,153
+150,000
| +47% | +$849K | 0.02% | 648 |
|
|
2018
Q3 | $3.35M | Buy |
319,153
+19,800
| +7% | +$208K | 0.02% | 699 |
|
|
2018
Q2 | $3.32M | Buy |
299,353
+84,000
| +39% | +$932K | 0.02% | 706 |
|
|
2018
Q1 | $1.72M | Buy |
215,353
+112,953
| +110% | +$904K | 0.01% | 880 |
|
|
2017
Q4 | $840K | Buy |
102,400
+80,500
| +368% | +$660K | 0.01% | 997 |
|
|
2017
Q3 | $136K | Hold |
21,900
| – | – | ﹤0.01% | 1078 |
|
|
2017
Q2 | $132K | Buy |
+21,900
| New | +$132K | ﹤0.01% | 1090 |
|